Form 8-K - Current report:
SEC Accession No. 0001193125-24-276426
Filing Date
2024-12-12
Accepted
2024-12-12 09:03:38
Documents
21
Period of Report
2024-12-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881353d8k.htm   iXBRL 8-K 70609
2 EX-2.1 d881353dex21.htm EX-2.1 560082
3 EX-10.1 d881353dex101.htm EX-10.1 99454
4 EX-10.2 d881353dex102.htm EX-10.2 53054
5 EX-10.3 d881353dex103.htm EX-10.3 46269
6 EX-10.4 d881353dex104.htm EX-10.4 31982
7 EX-99.1 d881353dex991.htm EX-99.1 33030
11 GRAPHIC g881353g1212034108144.jpg GRAPHIC 2447
12 GRAPHIC g881353g1212034108579.jpg GRAPHIC 2802
  Complete submission text file 0001193125-24-276426.txt   1235818

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA hura-20241211.xsd EX-101.SCH 2857
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hura-20241211_lab.xml EX-101.LAB 17995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hura-20241211_pre.xml EX-101.PRE 11266
24 EXTRACTED XBRL INSTANCE DOCUMENT d881353d8k_htm.xml XML 3711
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 241543366
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)